Clinical and molecular characterization of Hb Hofu in eastern India

International Journal of Laboratory Hematology

Volumn 36, Issue 1, 2014, Pages 71-76

  Purohit, P ^a   Mashon, R S ^a,b   Patel, S ^a   Dehury, S ^a   Pattanayak, C ^a   Das, K ^a   Nair, S ^c   Italia, K ^c   Bag, S ^d   Colah, R ^c   Patel, D K ^a  

^a VSS Medical College & Hospital   (India)

^b Indian Council for Medical Research   (India)

^c KEM HOSPITAL   (India)

^d MKCG MEDICAL COLLEGE   (India)

Author keywords

Eastern India; Hb Hofu; HPLC; Retention time; Sickle cell anemia

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN A; HEMOGLOBIN A2; HEMOGLOBIN F; HEMOGLOBIN HOFU; HEMOGLOBIN S; HEMOGLOBIN VARIANT; UNCLASSIFIED DRUG; HEMOGLOBIN BETA CHAIN;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ALPHA THALASSEMIA; ANEMIA; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GENE MUTATION; GLOBIN GENE; HEMOGLOBINOPATHY; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INDIA; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; MUTATIONAL ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING; ANEMIA, SICKLE CELL; ASYMPTOMATIC DISEASE; BLOOD; GENE EXPRESSION; GENETICS; HEMOGLOBINOPATHIES; ISOLATION AND PURIFICATION; MUTATION; PEDIGREE;

ADULT; ANEMIA, SICKLE CELL; ASYMPTOMATIC DISEASES; BETA-GLOBINS; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GENE EXPRESSION; HEMOGLOBIN A2; HEMOGLOBINOPATHIES; HEMOGLOBINS, ABNORMAL; HETEROZYGOTE; HUMANS; INDIA; MALE; MUTATION; PEDIGREE;

EID: 84892485902     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12128     Document Type: Article

References (12)

1. Miyaji T, Ohba Y, Yamamoto K, Shibata S, Iuchi I, Takenaka H. Japanese Haemoglobin Variant Nature. Nature 1968;217:89-90.
2. Braconnier F, Beuzard Y, El Gammal H, Coquelet MT, Rosa J. Detection of abnormal hemoglobin substitutions by a new method application to hb saki and to new cases of HbS hofu, ouled rabah and d. iran. Nouv Rev Fr Hematol 1975;15:527-38.
3. Brittenham G, Lozoff B, Harris JW, Nayudu NVS, Gravely M, Wilson JB, Lam H, Huisman THJ. Hemoglobin Hofu or α2β2 [126 (H4) Val →Glu] found in combination with hemoglobin S. Hemoglobin 1978;2:541-9.
4. Russo FM, John ME, Waterman MR, Simon LM, Sheehan RG. Hemoglobin Hofu (β126 Val→Glu) in a black American. Hemoglobin 1979;3:83-6.
5. 0-Thalassemla [Codons 8/9 (+g)] combination. Hemoglobin 1995;19: 301-6.
6. Patel DK. Clinical aspects of sickle cell disease in India. 5th Brazilian Symposium for Sickle cell disease and other hemoglobinopathies. Belo Horizonte, Brazil; 2009. Available from: http://www.cehmob.org.br/simposio/html/english/download.html
7. Old JM, Higgs DR. Gene analysis. In: The Thalassemias. Methods in Hematology, Vol.6. Weatherall DJ. (ed). Edinburgh: Churchill Livingstone; 1983:74-101.
8. Wu Y, Ugozzoli L, Pal BK, Wallace RB. Allele-specific enzymatic amplification of β-globin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci USA 1989;86:2757-60.
9. Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood 2000;95:360-2.
10. Kar BC, Satapathy RK, Kulozik AE, Kulozik M, Sirr S, Serjeant BE, Serjeant GR. Sickle cell disease in Orissa State, India. Lancet 1986;2:1198-201.
11. Suh DD, Kruss JS, Bures K. Influence of hemoglobin S adducts on hemoglobin A2 quantification by HPLC. Clin Chem 1996;42:113-4.
12. Working Party of the General Hematology Task Force of the British Committee for Standards in Hematology. Guideline: The laboratory diagnosis of hemoglobinopathies. Br J Hematol 1998; 101:783-92.